Cargando…
Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy
CAR T-cell therapy has revolutionized the treatment approach to patients with relapsed/refractory hematologic malignancies; however, there continues to be opportunity for improvement in treatment toxicity as well as response durability. Radiation therapy can play an important role in combined modali...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027336/ https://www.ncbi.nlm.nih.gov/pubmed/33842363 http://dx.doi.org/10.3389/fonc.2021.648655 |
_version_ | 1783675796724908032 |
---|---|
author | Fang, Penny Q. Gunther, Jillian R. Wu, Susan Y. Dabaja, Bouthaina S. Nastoupil, Loretta J. Ahmed, Sairah Neelapu, Sattva S. Pinnix, Chelsea C. |
author_facet | Fang, Penny Q. Gunther, Jillian R. Wu, Susan Y. Dabaja, Bouthaina S. Nastoupil, Loretta J. Ahmed, Sairah Neelapu, Sattva S. Pinnix, Chelsea C. |
author_sort | Fang, Penny Q. |
collection | PubMed |
description | CAR T-cell therapy has revolutionized the treatment approach to patients with relapsed/refractory hematologic malignancies; however, there continues to be opportunity for improvement in treatment toxicity as well as response durability. Radiation therapy can play an important role in combined modality treatments for some patients undergoing CAR T-cell therapy in various clinical settings. In this review, we discuss the current evidence for RT in the setting of CAR T-cell therapy for patients with hematologic malignancies and propose potential opportunities for future investigation of RT and CAR T-cell treatment synergy. Future research frontiers include investigation of hypotheses including radiation priming of CAR T-cell mediated death, pre-CAR T-cell tumor debulking with radiation therapy, and selection of high risk patients for early radiation salvage after CAR T cell therapy. |
format | Online Article Text |
id | pubmed-8027336 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-80273362021-04-09 Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy Fang, Penny Q. Gunther, Jillian R. Wu, Susan Y. Dabaja, Bouthaina S. Nastoupil, Loretta J. Ahmed, Sairah Neelapu, Sattva S. Pinnix, Chelsea C. Front Oncol Oncology CAR T-cell therapy has revolutionized the treatment approach to patients with relapsed/refractory hematologic malignancies; however, there continues to be opportunity for improvement in treatment toxicity as well as response durability. Radiation therapy can play an important role in combined modality treatments for some patients undergoing CAR T-cell therapy in various clinical settings. In this review, we discuss the current evidence for RT in the setting of CAR T-cell therapy for patients with hematologic malignancies and propose potential opportunities for future investigation of RT and CAR T-cell treatment synergy. Future research frontiers include investigation of hypotheses including radiation priming of CAR T-cell mediated death, pre-CAR T-cell tumor debulking with radiation therapy, and selection of high risk patients for early radiation salvage after CAR T cell therapy. Frontiers Media S.A. 2021-03-25 /pmc/articles/PMC8027336/ /pubmed/33842363 http://dx.doi.org/10.3389/fonc.2021.648655 Text en Copyright © 2021 Fang, Gunther, Wu, Dabaja, Nastoupil, Ahmed, Neelapu and Pinnix. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Oncology Fang, Penny Q. Gunther, Jillian R. Wu, Susan Y. Dabaja, Bouthaina S. Nastoupil, Loretta J. Ahmed, Sairah Neelapu, Sattva S. Pinnix, Chelsea C. Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy |
title | Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy |
title_full | Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy |
title_fullStr | Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy |
title_full_unstemmed | Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy |
title_short | Radiation and CAR T-cell Therapy in Lymphoma: Future Frontiers and Potential Opportunities for Synergy |
title_sort | radiation and car t-cell therapy in lymphoma: future frontiers and potential opportunities for synergy |
topic | Oncology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027336/ https://www.ncbi.nlm.nih.gov/pubmed/33842363 http://dx.doi.org/10.3389/fonc.2021.648655 |
work_keys_str_mv | AT fangpennyq radiationandcartcelltherapyinlymphomafuturefrontiersandpotentialopportunitiesforsynergy AT guntherjillianr radiationandcartcelltherapyinlymphomafuturefrontiersandpotentialopportunitiesforsynergy AT wususany radiationandcartcelltherapyinlymphomafuturefrontiersandpotentialopportunitiesforsynergy AT dabajabouthainas radiationandcartcelltherapyinlymphomafuturefrontiersandpotentialopportunitiesforsynergy AT nastoupillorettaj radiationandcartcelltherapyinlymphomafuturefrontiersandpotentialopportunitiesforsynergy AT ahmedsairah radiationandcartcelltherapyinlymphomafuturefrontiersandpotentialopportunitiesforsynergy AT neelapusattvas radiationandcartcelltherapyinlymphomafuturefrontiersandpotentialopportunitiesforsynergy AT pinnixchelseac radiationandcartcelltherapyinlymphomafuturefrontiersandpotentialopportunitiesforsynergy |